COVID-19 Vaccine Equity: A Health Systems and Policy Perspective

The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID -19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines. This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment. All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter.

Note: Funding Statement: None.

Declaration of Interests: None.

Keywords: ACT-A, capacity development, COVID-19 pandemic, vaccine equity, low-income countries, Research & Development ecosystem, Tanahashi health systems framework, technology transfer, TRIPS

Suggested Citation: Suggested Citation

van de Pas, Remco and Widdowson, Marc-Alain and Ravinetto, Raffaella and Nuggehalli Srinivas, Prashanth and Nuggehalli Srinivas, Prashanth and Ochoa, Theresa and Fofana, Thierno Oumar and Van Damme, Wim, COVID-19 Vaccine Equity: A Health Systems and Policy Perspective (May 31, 2021). Available at SSRN: https://ssrn.com/abstract=3856949 or http://dx.doi.org/10.2139/ssrn.3856949